LSAF
LeaderShares AlphaFactor US Core Equity ETF
The LeaderShares AlphaFactor US Core Equity ETF tracks an equal-weighted index of US stocks selected by multiple fundamental factors.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 133.3 M
ASSETS UNDER MGMT
75 bp
EXPENSES
Fund Basics
| Inception date | Oct 01, 2018 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Annually |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| MAPLEBEAR INC | 1.2 % |
| CROCS INC | 1.2 % |
| RYDER SYSTEM INC | 1.1 % |
| REGENERON PHARMACEUTICALS | 1.1 % |
| CONOCOPHILLIPS | 1.1 % |
| ETSY, INC. | 1.1 % |
| PAYCOM SOFTWARE INC | 1.1 % |
| EOG RESOURCES, INC. | 1.1 % |
| DOLLAR TREE INC | 1.1 % |
| FORTIVE CORP. | 1.1 % |
Constituent Breakdown
| Number of holdings | 101 |
| Herfindahl-Hirschman Index | 101 |
| Wgt avg mkt cap (mns) | $34,572 |
| Large cap (>$10bn) | 66.0% |
| Mid cap ($2-10bn) | 31.0% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 97.8% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 96.0 % |
 |
AUSTRALIA | 1.0 % |
Historical Performance
Standardized Performance (as of 09/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 18.1% | 19.0% | 13.4% | 19.0% | 10.6% | -- | -- | 9.9% |
| Dividend Yield | 0.0% | 0.8% | 0.6% | 0.8% | 1.5% | -- | -- | 1.2% |
| Total Returns | 18.1% | 19.9% | 14.1% | 19.7% | 12.1% | -- | -- | 11.1% | Ann. Volatility | 14.3% | 14.4% | 17.1% | 16.1% | 18.5% | -- | -- | 21.7% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.79 | 50% |
| MSCI EAFE | 0.58 | 42% |
| MSCI Emg Mkts | 0.25 | 20% |
Liquidity Measures
| Avg. volume (000) | 6 |
| ADV traded (mns) | $0 |
| Turnover | 0.3% |
| Avg. Bid/Ask (% of price) | 0.23% |
Technical Indicators
| 30d moving avg. (EMA) | $55.91 |
| Relative strength (RSI) | 59 |
| MACD/Signal | 0.66/0.56 |
| Bollinger Bands (Upper/Lower) | $58.15/$54.03 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. LSAF |
Expenses vs. LSAF |
ALTAR Score™ vs. LSAF |
|---|---|---|---|---|
| SYLD | Cambria Shareholder Yield ETF | 26.5% | -16 bp | +2.7% |
| PSAI | Pacer S&P 500 3AI TOP 100 ETF | 21.5% | -15 bp | +0.4% |
| SPVM | Invesco S&P 500 Value with Momentum ETF | 20.6% | -31 bp | +0.8% |
| PKW | Invesco Buyback Achievers ETF | 20.4% | -12 bp | +0.5% |
| LYLD | Cambria Large Cap Shareholder Yield ETF | 20.2% | -16 bp | +2.5% |
| FLOW | Global X U.S. Cash Flow Kings 100 ETF | 19.5% | -50 bp | +3.0% |
| FLQM | Franklin U.S. Mid Cap Multifactor Index ETF | 19.4% | -45 bp | +0.9% |
| VFMF | Vanguard U.S. Multifactor ETF | 19.0% | -57 bp | +0.8% |
| DEUS | Xtrackers Russell US Multifactor ETF | 18.4% | -58 bp | +0.3% |
| ONEV | State Street SPDR Russell 1000 Low Volatility Focus ETF | 18.1% | -55 bp | +0.6% |
Risk and Returns: LSAF vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 11/6/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
7.5%
ALTAR SCORE™
81st
PERCENTILE
SPECULATIVE
ETFRC RATING
There are 1,388 funds in the US Equity category with an average
ALTAR Score™ of 5.7% and a standard deviation
of 2.1%. LSAF's ALTAR Score™ is approximately 0.9 standard
deviations above the category average. This places LSAF in the 81st percentile
among funds in the category.
Sell-Side Consensus
$64.78
PRICE TARGET
+12.9%
UPSIDE